Overview

MintNeuro is a London-based chip designer building miniaturised neural sensing and stimulation integrated circuits for implantable brain-computer interfaces. The company spun out of Imperial College London’s Next Generation Neural Interfaces Lab in 2022, building on more than two decades of academic research into ultra-low-power implantable bioelectronics led by Prof. Tim Constandinou and colleagues.

Founders

MintNeuro was founded by Dorian Haci (CEO), Tim Constandinou (CTO) and Andrew Jackson (CSO). Haci holds a PhD from Imperial College London in microelectronics for implantable medical devices. Tim Denison, an Oxford professor and co-founder of Amber Therapeutics, chairs the company.

Technology focus

MintNeuro’s core technology is ultra-low-power application-specific integrated circuit (ASIC) design for implantable neural devices. The company’s chips are designed for the bandwidth, power-efficiency, and form-factor constraints of miniaturised implantable BCI systems, where conventional commercial chips are too power-hungry or too large to be suitable.

Motif Neurotech partnership

MintNeuro announced a multi-year commercial supply agreement with Motif Neurotech on 30 April 2026, becoming the contract silicon supplier for Motif’s DOT depression implant across pre-clinical, early clinical, and pivotal trial phases. The supply deal builds on the £4.7 million Brain Mesh joint project (a UK-funded research programme developing distributed networks of ultra-small wireless neural implants for mental health applications) which MintNeuro and Motif had been collaborating on before the supply agreement converted the relationship into a commercial silicon-supplier-plus-clinical-sponsor structure.

Strategic position

MintNeuro sits in the emerging BCI supply-chain layer that is structurally different from the early Neuralink vertical-integration template. Where Neuralink builds its own chips, implants, surgical robot, and clinical pathway, the silicon-supplier-plus-clinical-sponsor model (MintNeuro and Motif) more closely resembles how pharmaceutical and traditional medical-device companies build clinical pipelines on top of specialised manufacturing infrastructure. MintNeuro is one of the few European chip designers focused specifically on miniaturised neural implant silicon at scale.

Funding

MintNeuro raised £1 million in seed funding in late 2024 to advance its semiconductor technology for neural implants. On 7 October 2026 it announced a $5 million round led by Odyssey Ventures, with 33East, JSK Investments and Alumni Ventures joining and earlier backers including Empirical Ventures and Jumpspace Ventures investing again.